ºÚÁϳԹÏÍø

Community pharmacists in ºÚÁϳԹÏÍø play a key role in supporting patients transferring between regions or states for the Opioid Treatment Program (OTP) for reasons such as travel. The temporary transfer of dosing points guide provides support to help pharmacists manage these transfers safely and maintain continuity of care. 

Your role as the pharmacist

Discuss with the patient that ºÚÁϳԹÏÍø regulatory requirements may differ, such as the need for OTP scripts to be sent directly to the pharmacy. Let the patient know that the safety measures required for processing a script from another state or region could result in delays.

How can I make sure the script is legal?

• Check current ºÚÁϳԹÏÍø approvals: Check SafeScript ºÚÁϳԹÏÍø to make sure there are no other approved prescribers or supply for this patient. If the patient is visiting from interstate, the prescriber may apply for a ºÚÁϳԹÏÍø Health OTP approval.
• Ensure the script complies with the ºÚÁϳԹÏÍø legislation: Requirements for OTP script in ºÚÁϳԹÏÍø. Remember that non-PBS scripts may be dispensed as private prescriptions, but still need to comply with the ºÚÁϳԹÏÍø Poisons and Therapeutic Goods Legislation.
• ​ Verify patient identity: Ask for the patient's photo identification to verify their details.
• Contact the prescriber if required: If the script raises any concerns, contact the prescriber or nominated locum prescriber to discuss. If you need further support, contact your Local Health ​District.
  

H​ow can I make sure I dispense the script safely?

• Communication with other dosing points: Contact the previous dosing point to confirm and document last dose details including, the number of takeaway doses supplied.
• Review patient records: Review SafeScript and any other available clinical information. If any safety concerns arise, consult with both the patient and the prescriber.
• Clinical decision-making: Review the written instructions carefully. Takeaway dose guidelines vary between states, in such cases, you may need to contact the prescriber.
• Counselling: Ask the patient about any concerns they may have about their changed routine. Discuss proper storage, handing and disposal of takeaway doses. Discuss any changes to their treatment while travelling and the pharmacy's opening/dosing hours.
• Documentation: Dispense and record supply in the drug register as per ±·³§°Â°ù±ð²µ³Ü​l²¹â€‹t¾±´Ç²Ô²õ. Document any communications regarding the prescription and patient care.

For further advice and support:

1. Pharmacist-to-Pharmacist Advice Line 1300 369 772 (8:30am-5:00pm on weekdays)
2. Drug and Alcohol Specialist Advisory Service (DASAS) on 1800 023 687 (24-hour support)
3. Opioid Treatment Line 1800 642 428 (9:30am-5:00pm on weekdays)
   
   

For further information see Community pharmacists and the ºÚÁϳԹÏÍø O​pioid Treatment Program and ºÚÁϳԹÏÍø Opioid Treatment Program. For more clinical information, consult the ºÚÁϳԹÏÍø Clinical Guidelines Treatment of Opioid Dependence and LAIB guidance​.